Can Cannabinoids Help Treat Alcohol Use Disorder?

The endocannabinoid system plays a role in alcohol reward processing, and some evidence suggests cannabinoids could help treat alcohol use disorder, but concurrent use carries risks.

Marquez, Júlia Dalfovo et al.·International review of neurobiology·2024·Preliminary EvidenceNarrative Review
RTHC-05517Narrative ReviewPreliminary Evidence2024RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Narrative Review
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

The endocannabinoid system, particularly CB1 and CB2 receptors, modulates the brain's reward circuitry for alcohol. Some researchers propose cannabis as a substitute medication for AUD, but concurrent use may increase adverse outcomes.

Key Numbers

Review covers CB1 and CB2 receptor involvement in dopaminergic mesolimbic reward pathways related to alcohol.

How They Did This

Narrative review chapter examining preclinical and clinical evidence on the endocannabinoid system's role in alcohol reward, the therapeutic potential of cannabinoids for AUD, and risks of concurrent use.

Why This Research Matters

Alcohol use disorder is undertreated and current medications have limited effectiveness. If cannabinoids can reduce alcohol consumption or craving, they could address a major public health gap.

The Bigger Picture

The "cannabis as harm reduction for alcohol" debate is increasingly prominent as legalization expands. This review frames the biological plausibility while acknowledging the real-world complexity.

What This Study Doesn't Tell Us

Narrative review without systematic methodology. Most evidence comes from preclinical models. Human clinical trial data is extremely limited.

Questions This Raises

  • ?Would specific cannabinoid compounds be more effective than whole-plant cannabis for reducing alcohol consumption?
  • ?Does substituting cannabis for alcohol produce a net reduction in overall harm?

Trust & Context

Key Stat:
CB1 and CB2 receptors modulate alcohol reward pathways, but combined use carries its own risks
Evidence Grade:
Narrative review with primarily preclinical evidence and very limited human clinical data.
Study Age:
Published in 2024.
Original Title:
Cannabinoid for alcohol use disorder.
Published In:
International review of neurobiology, 178, 301-322 (2024)
Database ID:
RTHC-05517

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

Summarizes existing research without a strict systematic method.

What do these levels mean? →

Frequently Asked Questions

Can cannabis help someone stop drinking?

There is biological plausibility and some evidence suggesting cannabinoids could help reduce alcohol use, but using both substances together may increase adverse outcomes.

Is it safer to use cannabis instead of alcohol?

The evidence is mixed. While some propose cannabis as a less harmful substitute, concurrent use may increase overall risk.

Read More on RethinkTHC

Cite This Study

RTHC-05517·https://rethinkthc.com/research/RTHC-05517

APA

Marquez, Júlia Dalfovo; Dezanetti, Talissa; Walz, Roger; de Carvalho, Cristiane Ribeiro. (2024). Cannabinoid for alcohol use disorder.. International review of neurobiology, 178, 301-322. https://doi.org/10.1016/bs.irn.2024.08.005

MLA

Marquez, Júlia Dalfovo, et al. "Cannabinoid for alcohol use disorder.." International review of neurobiology, 2024. https://doi.org/10.1016/bs.irn.2024.08.005

RethinkTHC

RethinkTHC Research Database. "Cannabinoid for alcohol use disorder." RTHC-05517. Retrieved from https://rethinkthc.com/research/marquez-2024-cannabinoid-for-alcohol-use

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.